Josh Ney focuses his practice on patent litigation and prosecution in the pharmaceutical, biotechnology and chemical industries. Clients value Josh’s strategic thinking and technical savvy, which allow him to anticipate the risks and opportunities associated with protecting and commercializing their technology.
Josh represents pharmaceutical clients in patent litigation and prosecution matters involving new chemical entities, second medical uses, pharmaceutical formulations, synthetic processes and pharmaceutical polymorphs. His experience spans a range of therapeutic applications, including antiviral therapies, antibiotics, cardiovascular disease, central nervous system disorders, Huntington’s disease, lower urinary tract disorders, menopausal symptoms, osteoarthritis, and pain management.
Josh’s litigation experience includes handling and resolving matters in U.S. district courts and in inter partes review proceedings before the Patent Trial and Appeals Board. In addition to his pharmaceutical practice, Josh litigates and prosecutes patents related to chemical products and processes.
He is also experienced in providing clearance analyses for new products and in conducting due diligence for clients involved in financing transactions, mergers and acquisitions.
With a Ph.D. in organic chemistry and extensive studies in organic synthesis and synthetic methodology, Josh has the technical background needed to understand even the most complex innovations.
Professional and Community Involvement
Vice chair, American Intellectual Property Law Association (AIPLA), Biotechnology Committee
Member, Michigan Drug Discovery External Advisory Board
Member, Michigan Intellectual Property American Inn of Court
Michigan Lawyers Weekly, Up & Coming Lawyers, 2018
Michigan Super Lawyers, Rising Star, 2015-2018
DBusiness magazine, Top Young Lawyer, 2014
Managing Intellectual Property magazine, IP Star, 2013, 2014, 2016-2017